Mitochondrial Transplantation - From Animal Studies to Clinical Relevance

The Scientific Committee of WMS is honored to announce that Dr. James McCully, from the Harvard Medical School Department of Cardiac Surgery Boston Children’s Hospital, USA, will be joining us for our 10th Anniversary Edition of Targeting Mitochondria World Congress, which will be held in Berlin on October 28th-29th, 2019.

In his presentation entitled "Mitochondrial Transplantation - From Animal Studies to Clinical Relevance", Dr. McCully will share his studies using a novel therapy for cardioprotection based on mitochondrial transplantation. This approach uses replacement of native mitochondria damaged by ischemia/reperfusion injury with viable, respiration-competent mitochondria isolated from non-ischemic skeletal muscle tissue, obtained from the patient’s own body. Dr. McCully will provide results and insight from ischemia/ reperfusion protocols in regionally ischemic animal heart models and from a Phase 1 clinical trial in pediatric patients requiring institution of extracorporeal membrane oxygenation support. 

For more information about Targeting Mitochondria 2019: https://targeting-mitochondria.com